Trisenox and rash Patient Reports February 13, 2012

Trisenox Side Effects Report #4855372-0
Trisenox side effect was reported by a Health Professional from UNITED STATES on Apr 05, 2005. Male patient, 70 years of age, weighting 175.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, av dissociation, fatigue, oedema peripheral, platelet count decreased, pyrexia, rash . Trisenox dosage: unknown. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4887012-9
Trisenox side effect was reported by a Health Professional from UNITED STATES on Jan 06, 2006. Female patient, 60 years of age, weighting 150.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Trisenox. After drug was administered, patient experienced the following side effects: asthenia, back pain , fatigue, fluid retention, herpes zoster, neutrophil count increased, pyrexia, rash . Trisenox dosage: 17.04 MG QD INTRAVENOUS DRIP. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, FOSAMAX, FLEXERIL, LUNESTA, BACTRIM DS, ASCORBIC ACID. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4712479-6
Trisenox side effect was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2005. Female patient, 70 years of age, weighting 126.0 lb, was diagnosed with multiple myeloma  and was treated with Trisenox. After drug was administered, patient experienced the following side effects: asthenia, cardiac failure congestive, dyspnoea, platelet count decreased, pyrexia, rash , white blood cell count decreased. Trisenox dosage: 14 MG IVI. During the same period patient was treated with MELPHALAN, ASCORBIC ACID, OXYTROL, SANTURA, FOLIC ACID. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5270157-1
Trisenox side effect was reported by a Physician from JAPAN on Feb 28, 2007. Male patient, 79 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, facial palsy, hepatic function abnormal, herpes zoster, liver disorder, rash . Trisenox dosage: 8.0625MG. During the same period patient was treated with DISOPYRAMIDE PHOSPHATE, MEXILETINE HYDROCHLORIDE, NIFEDIPINE, HALOXAZOLAM, ZOLPIDEM TARTRATE. Patient was hospitalized and became disabled. Patient recovered.


Trisenox Side Effects Report #5320873-8
Trisenox side effect was reported by a Physician from JAPAN on Apr 23, 2007. Male patient, 79 years of age, was diagnosed with acute promyelocytic leukaemia, arrhythmia  and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, facial palsy, febrile neutropenia, herpes zoster, liver disorder, rash . Trisenox dosage: 8.0625 MG DAILY. During the same period patient was treated with DISOPYRAMIDE PHOSPHATE, MEXILETINE HYDROCHLORIDE, NIFEDIPINE, HALOXAZOLAM, ZOLPIDEM TARTRATE. Patient was hospitalized and became disabled. Patient recovered.

Trisenox Side Effects Report #5391724-0
Trisenox side effect was reported by a Physician from JAPAN on July 10, 2007. Male patient, 73 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood pressure systolic decreased, bone marrow failure, c-reactive protein increased, pleural effusion, rash , respiratory arrest, resuscitation, urine output decreased. Trisenox dosage: 9 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, METHOTREXATE, ARBEKACIN SULPHATE, ARBEKACIN SULPHATE, ARBEKACIN SULPHATE, PREDNISOLONE SUCCINATE, NEFAMOSTAT, LENOGRASTIM. Patient died on 05/06/2007.

Trisenox Side Effects Report #5127284-9
Trisenox side effect was reported by a Physician from JAPAN on Sept 26, 2006. Female patient, 61 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, c-reactive protein increased, condition aggravated, electrocardiogram qt prolonged, hepatic function abnormal, rash , white blood cell count decreased. Trisenox dosage: 9.15 MG QD INTRAVENOUS DRIP. During the same period patient was treated with SULFAMETHOXAZOLE, FLUCONAZOLE. Patient recovered.

Trisenox Side Effects Report #5087025-0
Trisenox side effect was reported by a Physician from JAPAN on Aug 09, 2006. Female patient, 57 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, c-reactive protein increased, headache , hepatic function abnormal, platelet count decreased, rash , white blood cell count decreased. Trisenox dosage: 7.77 MG QD INTRAVENOUS DRIP. Patient recovered.

Trisenox Side Effects Report #5260932-1
Trisenox side effect was reported by a Physician from JAPAN on Feb 20, 2007. Female patient, 32 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase decreased, blood urea decreased, electrocardiogram qt corrected interval prolonged, hepatic function abnormal, protein total decreased, rash , white blood cell count decreased. Trisenox dosage: 7.05 MG QD INTRAVENOUS DRIP. During the same period patient was treated with ELECTROLYTE. Patient was hospitalized. Patient recovered.


Trisenox Side Effects Report #5336511-4
Trisenox side effect was reported by a Physician from JAPAN on May 14, 2007. Female patient, 32 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase decreased, electrocardiogram qt prolonged, hepatic function abnormal, protein total decreased, rash , white blood cell count decreased. Trisenox dosage: 7.05 MG QD INTRAVENOUS DRIP. During the same period patient was treated with ELECTROLYTE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5164850-9
Trisenox side effect was reported by a Physician from JAPAN on Nov 14, 2006. Female patient, 32 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase decreased, electrocardiogram qt corrected interval prolonged, hepatic function abnormal, protein total decreased, rash , white blood cell count decreased. Trisenox dosage: 7.05 MG QD INTRAVENOUS DRIP. During the same period patient was treated with ELECTROLYTE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5175211-0
Trisenox side effect was reported by a Physician from JAPAN on Nov 22, 2006. Female patient, 32 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase decreased, electrocardiogram qt prolonged, hepatic function abnormal, protein total decreased, rash , white blood cell count decreased. Trisenox dosage: 7.05 MG QD INTRAVENOUS DRIP. During the same period patient was treated with ELECTROLYTE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5507315-4
Trisenox side effect was reported by a Physician from JAPAN on Oct 22, 2007. Female patient was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, gamma-glutamyltransferase increased, hepatic function abnormal, oedema, rash , weight increased. Trisenox dosage: 8.55 MG QD INTRAVENOUS DRIP. During the same period patient was treated with HYDROCORTISONE SUCCINATE, PREDNISOLONE, SPIRONOLACTONE, FUROSEMIDE. Patient recovered.